BICO Group AB (publ) (CLLKF)
| Market Cap | 127.01M -52.2% |
| Revenue (ttm) | 156.82M -9.1% |
| Net Income | -103.64M |
| EPS | -1.47 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 600 |
| Open | 1.530 |
| Previous Close | 1.530 |
| Day's Range | 1.530 - 1.530 |
| 52-Week Range | 1.522 - 3.951 |
| Beta | 2.54 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 19, 2026 |
About BICO Group AB
BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables and application... [Read more]
Financial Performance
In 2025, BICO Group AB's revenue was 1.50 billion, a decrease of -13.32% compared to the previous year's 1.73 billion. Losses were -1.09 billion, 19698.2% more than in 2024.
Financial numbers in SEK Financial StatementsNews
BICO Group AB Earnings Call Transcript: Q1 2026
Q1 2026 saw 11% organic growth, led by desktop instrument sales and strong performance in genomics and OEM segments, despite currency headwinds and weak U.S. academia. Restructuring and cost control improved adjusted EBITDA, while new bond issuance and property divestment strengthened liquidity.
BICO Group AB Quarterly report: Q1 2026
BICO Group AB has published its Q1 2026 quarterly earnings report on April 29, 2026.
BICO Group AB Slides: Q1 2026
BICO Group AB has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
BICO Group AB Earnings Call Transcript: Q4 2025
2025 ended with strong Lab Automation growth and improved cash position, despite overall negative organic sales growth and challenging market conditions. New capital was raised to support future growth, and product launches like GoSimple received strong interest.
BICO Group AB Annual report: Q4 2025
BICO Group AB has published its Q4 2025 annual report on February 18, 2026.
BICO Group AB Quarterly report: Q4 2025
BICO Group AB has published its Q4 2025 quarterly earnings report on February 18, 2026.
BICO Group AB Slides: Q4 2025
BICO Group AB has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 18, 2026.
BICO Group AB Earnings Call Transcript: Q3 2025
Q3 2025 delivered 12% organic sales growth and improved margins, driven by strong lab automation demand and major commercial wins. Divestments strengthened the cash position, while impairments impacted EBIT but not cash flow. Positive outlook with stable R&D and cost control.
BICO Group AB Quarterly report: Q3 2025
BICO Group AB has published its Q3 2025 quarterly earnings report on November 4, 2025.
BICO Group AB Slides: Q3 2025
BICO Group AB has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 4, 2025.
BICO Group AB Earnings Call Transcript: Q2 2025
Q2 2025 saw negative organic growth and profitability challenges, mainly due to project delays in Lab Automation, while Life Science Solutions delivered flat sales. The divestment of MatTek and Visikol strengthened the balance sheet, and operational improvements are underway to address project execution and margin pressures.
BICO Group AB Quarterly report: Q2 2025
BICO Group AB has published its Q2 2025 quarterly earnings report on August 19, 2025.
BICO Group AB Slides: Q2 2025
BICO Group AB has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 19, 2025.
4 X-Factors That Could Send BICO's Stock Soaring
The outlook is bright for this pioneering company.
